LEXINGTON, Ky. (Dec. 7, 2022) — The University of Kentucky Markey Cancer Center has received renewed funding from the American Cancer Society (ACS) to support a long-standing faculty research program.
The ACS’ Institutional Research Grant (IRG) is intended to help junior faculty establish and advance cancer research programs. The grant provides seed money to new investigators to initiate research projects and obtain preliminary results that help them build their programs and successfully compete for extramural funding.
The $360,000 grant will support a total of nine $40K pilot awards over the three-year funding period, which begins in January 2023.
The award is a renewal of the UK Markey Cancer Center’s IRG, which has been continuously funded since 1985.
“The ACS IRG has helped several UK faculty members advance their research programs over the past few decades,” said IRG principal investigator Kathleen O’Connor, Ph.D., a professor in the UK College of Medicine’s Department of Molecular and Cellular Biochemistry and associate director of cancer education and mentoring at UK Markey Cancer Center.
“The success of our previous ACS IRG awardees in obtaining extramural funding is a testament to the value this program has to advance cancer research,” O’Connor said. “The IRG program has helped to launch impactful research across a number of disciplines required to make progress against cancer including prevention, drug development, biology of cancer cells and health disparities.”
With the IRG funds, Markey will continue to host internal grant competitions for faculty. Three pilot awards will be granted each year for the next three years, with the next cycle opening for applications in early 2023.
Grant applications are reviewed by a panel of UK faculty with expertise in all areas of cancer research. The process will select grants with the highest scientific merit and greatest likelihood of obtaining extramural funding.
Markey’s IRG renewal was announced by the ACS in October, when they approved funding for 89 new Extramural Discovery Science research grants totaling $54.3 million.
The ACS IRG also allows Markey to compete for a Diversity in Cancer Research internship program grant, which has supported the Markey Science Training in Oncology, Networking and professional Growth (STRONG) Scholars Program over the past two years.
As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.
In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and named a “Diversity Champion” by INSIGHT into Diversity, a testament to our commitment to advance Kentucky and create a community of belonging for everyone. While our mission looks different in many ways than it did in 1865, the vision of service to our Commonwealth and the world remains the same. We are the University for Kentucky.